Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Bmy crawled time : 23:00 save search
FDA Advisory Committee Votes in Favor of Bristol Myers Squibb’s and 2seventy bio’s Abecma for Triple-Class Exposed Multiple Myeloma in Earlier Lines of Therapy
Published: 2024-03-15 (Crawled : 23:00) - biospace.com/
TSVT | $4.65 -8.1% -8.82% 710K
|
|
| O: 2.27%
H: 8.4%
C: -0.99%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -0.32%
H: 1.67%
C: 0.04%
fda therapy
Bristol Myers Squibb to Report Results for First Quarter 2024 on April 25, 2024
Published: 2024-03-11 (Crawled : 23:00) - biospace.com/
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.2%
H: 1.22%
C: 0.85%
first report results
Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 3.52%
H: 0.0%
C: -1.18%
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.06%
H: 2.34%
C: 2.29%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 0.37%
H: 0.74%
C: 0.28%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.14%
H: 0.35%
C: 0.07%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.34%
H: 0.23%
C: -1.13%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 1.22%
H: 0.07%
C: -0.43%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.96%
H: 1.75%
C: 1.75%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -0.18%
H: 0.48%
C: -1.91%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
ZLAB | News | $14.2 3.5% 3.38% 690K
|
Health Technology
|
| O: -1.15%
H: 1.03%
C: -1.5%
VRTX | News | $393.51 0.1% 0.1% 950K
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -0.32%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
IPHA | $2.4 -0.42% -0.42% 11K
|
Health Technology
|
| O: -3.1%
H: 1.2%
C: -0.8%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 3.8%
H: 1.1%
C: -1.17%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: -3.72%
H: 0.58%
C: -3.82%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.26%
H: 0.73%
C: -0.36%
ARGX | $358.65 -2.06% -2.11% 240K
|
Health Technology
|
| O: -2.3%
H: 1.65%
C: 0.83%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: -1.4%
expansion growth market
Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028, Assesses DelveInsight
Published: 2024-01-23 (Crawled : 23:00) - prnewswire.com
TRUMF | $17.112 -17.59% 1.5K
|
Health Technology
|
| O: -4.99%
H: 0.0%
C: -0.06%
TRUMY | $16.69 0.79% 54K
|
Manufacturing
|
| O: -1.36%
H: 0.0%
C: -0.82%
WST | $377.33 -0.01% 0.0% 320K
|
Health Technology
|
| O: 0.67%
H: 0.46%
C: -1.49%
TFX | News | $207.38 -0.44% 0.0% 150K
|
Health Technology
|
| O: 0.18%
H: 0.52%
C: -2.57%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.61%
H: 1.52%
C: 0.03%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.16%
H: 0.84%
C: 0.08%
BSX | $67.42 -0.8% -0.53% 5.9M
|
Health Technology
|
| O: -0.18%
H: 0.5%
C: -0.98%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 1.44%
H: 0.0%
C: 0.0%
PODD | $164.71 -0.93% -0.94% 590K
|
Health Technology
|
| O: 0.07%
H: 1.08%
C: -1.59%
drug global growth market
Antipsychotic Drugs Market Forecasts 2023-2028 - Market Set for Growth, Forecasted at CAGR of 5.94% from 2023 to 2028
Published: 2023-12-15 (Crawled : 23:00) - prnewswire.com
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
| Email alert
Add to watchlist
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
| Email alert
Add to watchlist
set market
Locally Advanced Pancreatic Cancer Market Report 2023-2028: Recent Advancements in Immunotherapy Inject New Hope into LAPC Market
Published: 2023-11-21 (Crawled : 23:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 0.76%
H: 0.0%
C: -0.05%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.56%
H: 1.53%
C: 1.37%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.89%
H: 0.33%
C: -0.16%
report hope cancer pancreatic immunotherapy market
Rising R&D Investment and Government Support Fuel Expansion of Global Duchenne Muscular Dystrophy Drugs Market
Published: 2023-10-24 (Crawled : 23:00) - prnewswire.com
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: 0.1%
H: 1.77%
C: 0.89%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 2.75%
H: 0.46%
C: -1.76%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -0.18%
H: 1.34%
C: 1.05%
PTCT | $24.71 -1.79% -1.82% 820K
|
Health Technology
|
| O: -1.34%
H: 2.23%
C: 1.62%
LXRX | News | $1.625 0.31% 0.31% 3.7M
|
Health Technology
|
| O: -1.68%
H: 0.85%
C: -2.99%
expansion global duchenne market
Global Antibodies Market Set to Soar, Projected to Reach $524.8 Billion by 2030 with a CAGR of 12.9%
Published: 2023-09-12 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.8%
H: 0.0%
C: 0.0%
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.63%
H: 0.5%
C: 0.31%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.05%
H: 0.73%
C: 0.14%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.02%
H: 0.55%
C: -1.0%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
RARE F | $43.38 -1.65% -1.68% 770K
|
Health Technology
|
| O: -0.02%
H: 1.4%
C: -1.07%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.99%
H: 0.0%
C: 0.0%
MOR | $18.02 -0.11% -0.11% 590K
|
Health Technology
|
| O: 0.0%
H: 0.63%
C: -1.98%
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: -0.34%
H: 0.51%
C: -8.5%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.0%
H: 0.53%
C: -1.76%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.07%
H: 0.53%
C: -1.05%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.37%
H: 0.34%
C: -0.81%
reach global set market
Bristol Myers Squibb to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Published: 2023-09-01 (Crawled : 23:00) - biospace.com/
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: 0.46%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.29%
H: 0.91%
C: 0.31%
conference global
Inhibrx Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
Published: 2023-08-07 (Crawled : 23:00) - biospace.com/
TSVT | $4.65 -8.1% -8.82% 710K
|
|
| O: -0.16%
H: 0.0%
C: -0.33%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.03%
H: 0.41%
C: -0.07%
INBX | $34.47 -0.41% -0.41% 420K
|
Health Technology
|
| O: 0.73%
H: 0.0%
C: -6.89%
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: -7.93%
financial results
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $23.78 -0.96% -0.97% 1.8M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
NBIX M | $132.49 -0.56% -0.56% 550K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
| Email alert
Add to watchlist
UCBJY | $64.07 -4.38% 72K
|
Manufacturing
| Email alert
Add to watchlist
UCBJF | $126.05 -39.66% 100
|
Health Technology
| Email alert
Add to watchlist
AZNCF | $140.15 -4.19% 560
|
Health Technology
| Email alert
Add to watchlist
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
| Email alert
Add to watchlist
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
| Email alert
Add to watchlist
report business life global therapeutics
Global Small Molecule API Market Report 2023: Growing Demand for Small Molecule Drugs Fuels the Sector
Published: 2023-05-16 (Crawled : 23:00) - prnewswire.com
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 0.44%
H: 1.8%
C: 1.2%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.28%
H: 0.17%
C: -0.5%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.06%
H: 0.43%
C: -0.79%
ALB | News | $111.8 -2.26% 0.63% 2.2M
|
Process Industries
|
| O: -0.27%
H: 2.2%
C: 1.4%
report global growing market
Bolt Biotherapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Published: 2022-08-10 (Crawled : 23:00) - biospace.com/
GNMSF | $281.02 3.83% 210
|
Health Technology
|
| O: -0.39%
H: 5.07%
C: -0.05%
BOLT | $1.15 3.6% 3.48% 89K
|
|
| O: 3.07%
H: 8.51%
C: 7.23%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.32%
H: 0.16%
C: -0.45%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: 2.33%
H: 0.64%
C: -0.72%
update results
Opdivo® (nivolumab) in Combination with CABOMETYX® (cabozantinib) Demonstrates Continued Survival Benefits with Over Two Years of Follow-Up in the CheckMate -9ER Trial in First-Line Advanced Renal Cell Carcinoma
Published: 2022-02-14 (Crawled : 23:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.27%
H: 0.2%
C: 0.0%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -0.01%
H: 0.22%
C: -0.09%
EXEL | $22.47 -1.75% -1.78% 2.6M
|
Health Technology
|
| O: -0.27%
H: 1.12%
C: -0.59%
opdivo renal trial cel cell carcinoma nivolumab
Compugen Presents Preliminary Results from Phase 1/2 Dose Escalation Study of COM701 with Opdivo® and BMS-986207 (Anti-TIGIT Antibody) at SITC 2021
Published: 2021-11-12 (Crawled : 23:00) - biospace.com/
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -1.06%
H: 0.0%
C: 0.0%
CGEN | $2.03 3.57% 3.45% 450K
|
Health Technology
|
| O: -10.51%
H: 0.0%
C: 0.0%
phase 1 results antibody
Global Atopic Dermatitis Drugs Market Report 2021: Rising Incident of Food Allergies Intensifying Atopic Dermatitis - Forecast to 2026
Published: 2021-08-19 (Crawled : 23:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.56%
H: 0.87%
C: 0.7%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.17%
H: 0.67%
C: 0.26%
LLY | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
|
| O: 0.04%
H: 1.71%
C: 0.18%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.14%
H: 1.16%
C: 0.61%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
food dermatitis drug atopic dermatitis
Insights on the Targeted Therapeutics Global Market to 2031 - Featuring Sanofi, Takeda Pharmaceutical and Novartis Among Others
Published: 2021-07-30 (Crawled : 23:00) - prnewswire.com
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
| Email alert
Add to watchlist
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
| Email alert
Add to watchlist
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo (nivolumab) plus Yervoy (ipilimumab) for Treatment of Mismatch Repair Deficient
Published: 2021-05-21 (Crawled : 23:00) - biospace.com/
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.36%
H: 1.01%
C: -0.28%
treatment positive chmp nivolumab
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.